Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Imatinib in Relapsed/Refractory c-Kit Positive AML
NCT00707408Phase 2Completed
- Sponsor
- CHU de Nantes
- Start
- Feb 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in acute myeloid leukemia (AML), sponsored by CHU de Nantes. Started Feb 2004; status: completed.
02
Drugs
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00707408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00707408.